Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $21,129 - $34,530
-465 Reduced 0.24%
192,167 $12.6 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $264,689 - $517,995
6,395 Added 3.43%
192,632 $8.67 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $9.14 Million - $14.3 Million
126,342 Added 210.94%
186,237 $13.5 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $274,244 - $358,687
3,145 Added 5.54%
59,895 $6.43 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $268,912 - $355,418
2,855 Added 5.3%
56,750 $6.29 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $1.31 Million - $1.52 Million
10,939 Added 25.47%
53,895 $6.9 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $201,309 - $262,493
1,844 Added 4.49%
42,956 $5.72 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $253,057 - $291,770
2,522 Added 6.54%
41,112 $4.45 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $678,695 - $837,555
-6,686 Reduced 14.77%
38,590 $4.06 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $372,203 - $456,630
4,334 Added 10.59%
45,276 $4.71 Million
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $322,456 - $410,052
4,433 Added 12.14%
40,942 $3.51 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $470,307 - $774,117
9,794 Added 36.66%
36,509 $2.68 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $987,119 - $1.68 Million
26,715 New
26,715 $1.39 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Aristotle Atlantic Partners, LLC Portfolio

Follow Aristotle Atlantic Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.